Table 1 Association of ITPKA expression with clinicopathological features in HCCs
From: ITPKA expression is a novel prognostic factor in hepatocellular carcinoma
Clinical features | Cases | ITPKA expression | P value | |
|---|---|---|---|---|
low level (%) | high level (%) | |||
Age (years old) | 0.945 | |||
≤50 | 63 | 32 (50.8 %) | 31 (49.2 %) | |
>50 | 72 | 37 (51.4 %) | 35 (48.6 %) | |
Gender | 1.000 | |||
Male | 128 | 65 (50.8 %) | 63 (49.2 %) | |
Female | 7 | 4 (57.1 %) | 3 (42.9 %) | |
HBsAg | 0.201 | |||
Negative | 15 | 10 (66.7 %) | 5 (33.3 %) | |
Positive | 120 | 59 (49.2 %) | 61 (50.8 %) | |
AFP (μg/L) | 0.212 | |||
≤25 | 48 | 28 (58.3 %) | 20 (41.7 %) | |
>25 | 87 | 41 (47.1 %) | 46 (52.9 %) | |
Cirrhosis | 0.569 | |||
No | 23 | 13 (56.5 %) | 10 (43.5 %) | |
Yes | 112 | 56 (50.0 %) | 56 (50.0 %) | |
Tumor size (cm) | 0.126 | |||
≤5 | 56 | 33 (58.9 %) | 23 (41.1 %) | |
>5 | 79 | 36 (45.6 %) | 43 (54.4 %) | |
Tumor number | 0.116 | |||
Solitary | 104 | 57 (54.8 %) | 47 (45.2 %) | |
Multiple | 31 | 12 (38.7 %) | 19 (61.3 %) | |
Tumor encapsulation | 0.455 | |||
Complete | 43 | 24 (55.8 %) | 19 (44.2 %) | |
None | 92 | 45 (48.9 %) | 47 (51.1 %) | |
Vascular invasion | 0.001 | |||
Absent | 114 | 65 (57.0 %) | 49 (43.0 %) | |
Present | 21 | 4 (19.0 %) | 17 (81.0 %) | |
Edmondson-Steiner | 0.106 | |||
I-II | 79 | 45 (57.0 %) | 34 (43.0 %) | |
III-IV | 56 | 24 (42.9 %) | 32 (57.1 %) | |
TNM stage | 0.005 | |||
I | 93 | 55 (59.1 %) | 38 (40.9 %) | |
II-III | 42 | 14 (33.3 %) | 28 (66.7 %) | |